Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eisdCfbwoceZzPnhIsPQ

January 28, 2013
Sign upForwardArchiveAdvertise
 

  Top Stories 
  • Nordion files new statement of claim involving MAPLE project
    Nordion is now seeking damages worth $242 million from Atomic Energy of Canada Ltd. -- an amount 85% less than the company originally sought from AECL for damages involving the cancellation of the MAPLE nuclear reactor project. Nordion lost its previous arbitration battle with the agency in September, and this new filing is anticipated to go to trial in 2014. Ottawa Business Journal (Ontario) (1/21) LinkedInFacebookTwitterEmail this Story
  Medical Focus 
  • Peginesatide may raise heart risks without dialysis
    Peginesatide, an erythropoiesis-stimulating agent, was determined to be as safe and effective as epoetin in treating patients with advanced kidney disease and anemia receiving hemodialysis, according to a study in the New England Journal of Medicine. A second study in the same journal found that peginesatide without dialysis was as effective as darbepoetin for patients with advanced chronic kidney disease and anemia, but peginesatide was linked to higher rates of cardiovascular events and death. DoctorsLounge.com/HealthDay News (1/23) LinkedInFacebookTwitterEmail this Story
  Regulatory & Policy 
  • Senator urges action on final Sunshine Act regulations
    Sen. Chuck Grassley, R-Iowa, has asked the Obama administration to issue the long-awaited final rules on the Sunshine Act, saying the delays "are disrupting the considerable efforts of the pharmaceutical and medical device manufacturers that are already investing in systems to comply with the law." The law requires device and drug firms to report financial ties with doctors. MassDevice.com (Boston) (1/24) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
  ASNC News 
  • NC Today -- Bringing Value to Your Nuclear Cardiology Lab
    Early-bird registration is now available for ASNC's popular program, Nuclear Cardiology Today -- Bringing Value to Your Nuclear Cardiology Lab. This program will be held April 26-28 in Fort Lauderdale, Fla., for physicians and technologists. It offers the most up-to-date protocols in imaging procedures, so physicians and technologists practicing nuclear cardiology should plan to attend! New procedures that reduce radiation dose and cutting-edge technologies will also be highlights this year. Register today by going to asnc.org/nctoday. LinkedInFacebookTwitterEmail this Story
  • Nuclear Cardiology for the Technologist
    The Nuclear Cardiology for the Technologist program is developed with technologists in mind and offers an overview of topics such as radiation reduction, quality control requirements and protocol selection for SPECT and PET. Expert faculty will discuss new developments in the field and review cases that put guidelines into practice. This program will be held April 26-28 in Fort Lauderdale, Fla. Now is a good time to make your hotel reservation, book your travel and register! LinkedInFacebookTwitterEmail this Story
Learn more about ASNC ->ASNC Home | Join ASNC | Education and Meetings
Annual Meeting | Journal of Nuclear Cardiology

  SmartQuote 
There's much to be said for challenging fate instead of ducking behind it."
--Diana Trilling,
American literary critic and author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent ASNC SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information